Nazmeen Aarifa, Chen Guangping, Ghosh Tamal Kanti, Maiti Smarajit
Dept. of Biochemistry, Cell & Molecular Therapeutics Lab, Oriental Institute of Science & Technology, Midnapore, 721101 India.
Venture I OSU Laboratory, Oklahoma Technology & Research Park, 1110 S. Innovation Way, Stillwater, OK 74074 USA.
Cancer Cell Int. 2020 Mar 4;20:70. doi: 10.1186/s12935-020-1153-y. eCollection 2020.
Estrogen sulfotransferase catalyzes conjugation of sulfuryl-group to estradiol/estrone and regulates E2 availability/activity via estrogen-receptor or non-receptor mediated pathways. Sulfoconjugated estrogen fails to bind estrogen-receptor (ER). High estrogen is a known carcinogen in postmenopausal women. Reports reveal a potential redox-regulation of hSULT1E1/E2-signalling. Further, oxidatively-regulated nuclear-receptor-factor 2 (Nrf2) and NFκβ in relation to hSULT1E1/E2 could be therapeutic-target via cellular redox-modification.
Here, oxidative stress-regulated SULT1E1-expression was analyzed in human breast carcinoma-tissues and in rat xenografted with human breast-tumor. Tumor and its surrounding tissues were obtained from the district-hospital. Intracellular redox-environment of tumors was screened with some in vitro studies. RT-PCR and western blotting was done for SULT1E1 expression. Immunohistochemistry was performed to analyze SULT1E1/Nrf2/NFκβ localization. Tissue-histoarchitecture/DNA-stability (comet assay) studies were done.
Oxidative-stress induces SULT1E1 via Nrf2/NFκβ cooperatively in tumor-pathogenesis to maintain the required proliferative-state under enriched E2-environment. Higher malondialdehyde/non-protein-soluble-thiol with increased superoxide-dismutase/glutathione-peroxidase/catalase activities was noticed. SULT1E1 expression and E2-level were increased in tumor-tissue compared to their corresponding surrounding-tissues.
It may be concluded that tumors maintain a sustainable oxidative-stress through impaired antioxidants as compared to the surrounding. Liver-tissues from xenografted rat manifested similar E2/antioxidant dysregulations favoring pre-tumorogenic environment.
雌激素磺基转移酶催化硫酸基团与雌二醇/雌酮结合,并通过雌激素受体或非受体介导的途径调节雌二醇的可用性/活性。硫酸结合雌激素不能与雌激素受体(ER)结合。高雌激素是绝经后女性已知的致癌物。报告显示人SULT1E1/雌二醇信号存在潜在的氧化还原调节。此外,与hSULT1E1/雌二醇相关的氧化调节核受体因子2(Nrf2)和核因子κB可能是通过细胞氧化还原修饰的治疗靶点。
在此,分析了人乳腺癌组织和人乳腺肿瘤异种移植大鼠中氧化应激调节的SULT1E1表达。肿瘤及其周围组织取自地区医院。通过一些体外研究筛选肿瘤的细胞内氧化还原环境。进行逆转录聚合酶链反应(RT-PCR)和蛋白质印迹法检测SULT1E1表达。进行免疫组织化学分析SULT1E1/Nrf2/NFκB定位。进行组织组织结构/DNA稳定性(彗星试验)研究。
在肿瘤发生过程中,氧化应激通过Nrf2/NFκB协同诱导SULT1E1,以在富含雌二醇的环境中维持所需的增殖状态。观察到丙二醛/非蛋白可溶性硫醇含量较高,同时超氧化物歧化酶/谷胱甘肽过氧化物酶/过氧化氢酶活性增加。与相应的周围组织相比,肿瘤组织中SULT1E1表达和雌二醇水平升高。
可以得出结论,与周围组织相比,肿瘤通过受损的抗氧化剂维持可持续的氧化应激。异种移植大鼠的肝脏组织表现出类似的雌二醇/抗氧化剂失调,有利于肿瘤前环境。